These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36823537)

  • 41. Clinical and epidemiological characteristics of patients seeking COVID-19 testing in a private centre in Malaysia: Is there a role for private healthcare in battling the outbreak?
    Chow YP; Chin BHZ; Loo JM; Moorthy LR; Jairaman J; Tan LH; Tay WWY
    PLoS One; 2021; 16(10):e0258671. PubMed ID: 34648575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening and Testing Pregnant Patients for SARS-CoV-2: First-Wave Experience of a Designated COVID-19 Hospitalization Centre in Montréal.
    Trahan MJ; Mitric C; Malhamé I; Abenhaim HA
    J Obstet Gynaecol Can; 2021 May; 43(5):571-575. PubMed ID: 33358711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bondi and beyond. Lessons from three waves of COVID-19 from 2020.
    Capon A; Sheppeard V; Gonzalez N; Draper J; Zhu A; Browne M; Sullivan E; Mihajlovic M; Rockett R; Ferson MJ
    Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April-May 2020: implications for policy and practice.
    Tang S; Sanchez Perez M; Saavedra-Campos M; Paranthaman K; Myers R; Fok J; Crawley-Boevey E; Dun-Campbell K; Janarthanan R; Fernandez E; Vusirikala A; Patel B; Ma T; Amin-Chowdhury Z; Shetty N; Zambon M; Bell A; Wynne-Evans E; Chow Y; Ladhani S
    Age Ageing; 2021 May; 50(3):649-656. PubMed ID: 33620453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Comprehensive COVID-19 Testing Program Outcomes in a US Dental Clinical Care Academic Setting.
    Choi SE; Sima C; Colom LP; Nguyen GT; Giannobile WV
    JAMA Netw Open; 2022 Dec; 5(12):e2246530. PubMed ID: 36512355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Robust Testing in Outpatient Settings to Explore COVID-19 Epidemiology: Disparities in Race/Ethnicity and Age, Salt Lake County, Utah, 2020.
    Ahmed SM; Shah RU; Fernandez V; Grineski S; Brintz B; Samore MH; Ferrari MJ; Leung DT; Keegan LT
    Public Health Rep; 2021 May; 136(3):345-353. PubMed ID: 33541222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beliefs and practices among primary care physicians during the first wave of the COVID-19 pandemic in Baden-Wuerttemberg (Germany): an observational study.
    Roth C; Breckner A; Moellinger S; Schwill S; Peters-Klimm F; Szecsenyi J; Stengel S; Wensing M
    BMC Fam Pract; 2021 May; 22(1):86. PubMed ID: 33952205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
    Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
    J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
    Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
    J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.
    Stratil JM; Biallas RL; Burns J; Arnold L; Geffert K; Kunzler AM; Monsef I; Stadelmaier J; Wabnitz K; Litwin T; Kreutz C; Boger AH; Lindner S; Verboom B; Voss S; Movsisyan A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD015085. PubMed ID: 34523727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [COVID-19 in obstetric anesthesia : Prospective surveillance of peripartum infections with SARS-CoV-2 and peripartum course of disease in affected women].
    Sitter M; Schlesinger T; Reinhold AK; Scholler A; von Heymann C; Welfle S; Bartmann C; Wöckel A; Kleinschmidt S; Schneider S; Gottschalk A; Greve S; Wermelt JZ; Wiener R; Schulz F; Chappell D; Brunner M; Neumann C; Meybohm P; Kranke P;
    Anaesthesiologie; 2022 Jun; 71(6):452-461. PubMed ID: 34812895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
    Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
    Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 in children: analysis of the first pandemic peak in England.
    Ladhani SN; Amin-Chowdhury Z; Davies HG; Aiano F; Hayden I; Lacy J; Sinnathamby M; de Lusignan S; Demirjian A; Whittaker H; Andrews N; Zambon M; Hopkins S; Ramsay ME
    Arch Dis Child; 2020 Dec; 105(12):1180-1185. PubMed ID: 32796006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers.
    Mostafa A; Kandil S; El-Sayed MH; Girgis S; Hafez H; Yosef M; Saber S; Ezzelarab H; Ramadan M; Afifi I; Hassan F; Elsayed S; Reda A; Fattuh D; Mahmoud A; Mansour A; Sabry M; Habeb P; Ebeid FS; Saleh A; Mansour O; Omar A; El-Meteini M
    Int J Epidemiol; 2021 Mar; 50(1):50-61. PubMed ID: 33094320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing Two Testing Strategies: Universal versus Symptomatic SARS-CoV-2 Testing in Obstetric Patients.
    Aderibigbe OA; Lappen JR; Albertini M; Gibson KS
    Am J Perinatol; 2022 Jul; 39(9):909-914. PubMed ID: 34839480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.